| NCT04289571 |
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease |
https://ClinicalTrials.gov/show/NCT04289571 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2022-12-31 |
| NCT02376868 |
Maestro Agreement and Precision Study II |
https://ClinicalTrials.gov/show/NCT02376868 |
Completed |
Topcon Medical Systems, Inc. |
2015-09-30 |
| NCT04101721 |
Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity |
https://ClinicalTrials.gov/show/NCT04101721 |
Recruiting |
Regeneron Pharmaceuticals |
2022-04-01 |
| NCT03859245 |
Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders for Alzheimer’s Disease Prevention |
https://ClinicalTrials.gov/show/NCT03859245 |
Recruiting |
Bristlecone Health, Inc. |
2020-09-30 |
| NCT03824782 |
The Effect of Eyemasks on Neonatal Stress Following Dilated Retinal Examination |
https://ClinicalTrials.gov/show/NCT03824782 |
Completed |
Sunnybrook Health Sciences Centre |
2017-06-30 |
| NCT03343730 |
RetinaVue Diabetic Screening |
https://ClinicalTrials.gov/show/NCT03343730 |
Recruiting |
Bassett Healthcare |
2018-10-01 |
| NCT03274596 |
Effect of Vitamin E for Prevention of Retinopathy of Prematurity: A Randomized Clinical Trial. |
https://ClinicalTrials.gov/show/NCT03274596 |
Completed |
Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes |
2015-10-01 |
| NCT03242031 |
Medico-economic Comparison Between Treatment With Panretinal Photocoagulation by Laser in 1 Session Versus 4 Sessions in Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT03242031 |
Recruiting |
Centre Hospitalier Universitaire Dijon |
2021-03-31 |
| NCT03238963 |
A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated. |
https://ClinicalTrials.gov/show/NCT03238963 |
Completed |
Boehringer Ingelheim |
2020-02-14 |
| NCT03201588 |
Multi-Center Study to Determine the Role of Fatty Acids in Serum in Preventing Retinopathy of Prematurity (MDM) |
https://ClinicalTrials.gov/show/NCT03201588 |
Completed |
Göteborg University |
2019-11-15 |
| NCT03197870 |
The TIME-2b Study: A Study of AKB-9778, a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR) |
https://ClinicalTrials.gov/show/NCT03197870 |
Completed |
Aerpio Therapeutics |
2019-01-09 |
| NCT03161652 |
Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03161652 |
Recruiting |
Universidad Nacional Autonoma de Mexico |
2022-05-31 |
| NCT03154723 |
Effects of Early Vitamin A Supplementation on the Risk for Retinopathy of Prematurity in Extremely Preterm Infants |
https://ClinicalTrials.gov/show/NCT03154723 |
Completed |
Zhengzhou Children’s Hospital, China |
2017-12-31 |
| NCT03150654 |
The Effect of Laser Treatment on Macular Pigment of Eye in Cases With Diabetes |
https://ClinicalTrials.gov/show/NCT03150654 |
Completed |
Afyon Kocatepe University Hospital |
2016-06-08 |
| NCT03148132 |
VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP |
https://ClinicalTrials.gov/show/NCT03148132 |
Completed |
Universidad Autonoma de San Luis Potosà |
2018-08-30 |
| NCT03113006 |
The Individually-Marked Panretinal Laser phoTocoagulation for Proliferative Diabetic Retinopathy Study (TREAT) |
https://ClinicalTrials.gov/show/NCT03113006 |
Completed |
Odense University Hospital |
2019-08-27 |
| NCT03085784 |
Intravitreal Aflibercept Injection for Radiation Retinopathy Trial |
https://ClinicalTrials.gov/show/NCT03085784 |
Recruiting |
Greater Houston Retina Research |
2021-10-31 |
| NCT03065881 |
RETeval All Comers Trial (REACT) |
https://ClinicalTrials.gov/show/NCT03065881 |
Active, not recruiting |
LKC Technologies, Inc. |
2020-12-31 |
| NCT02995629 |
Patient Comfort Using Green vs. Yellow Pan Retinal Photocoagulation |
https://ClinicalTrials.gov/show/NCT02995629 |
Completed |
Wills Eye |
2016-10-31 |
| NCT02911311 |
Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02911311 |
Enrolling by invitation |
Sun Yat-sen University |
2019-12-31 |
| NCT02879422 |
Genetic Markers and Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02879422 |
Recruiting |
CHU de Reims |
2020-04-16 |
| NCT02874313 |
CPAP Effect on the Progression of Diabetic Retinopathy in Patients With Sleep Apnea |
https://ClinicalTrials.gov/show/NCT02874313 |
Active, not recruiting |
Hospital Universitario La Paz |
2020-10-31 |
| NCT02866734 |
Diabetic Retinopathy Screening in Private Practice |
https://ClinicalTrials.gov/show/NCT02866734 |
Completed |
The University of Hong Kong |
2017-12-13 |
| NCT02863354 |
Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02863354 |
Active, not recruiting |
Greater Houston Retina Research |
2019-07-31 |
| NCT02858076 |
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR |
https://ClinicalTrials.gov/show/NCT02858076 |
Completed |
Jaeb Center for Health Research |
2020-01-31 |
| NCT02857491 |
Intravitreal Injection of Ranibizumab Versus Sham Before Vitrectomy in Patients With Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02857491 |
Completed |
Sun Yat-sen University |
2017-09-30 |
| NCT02834663 |
Effects of Intravitreal Ranibizumab for Macular Edema With Nonproliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02834663 |
Completed |
Wonkwang University Hospital |
2019-02-28 |
| NCT02826655 |
Adaptive Optics for Ophthalmic Technologies |
https://ClinicalTrials.gov/show/NCT02826655 |
Recruiting |
Duke University |
2021-06-30 |
| NCT02820662 |
Study of the Implication of Omega-3 Polyunsaturated Fatty Acids in Retinopathy of Prematurity in New-born Infants |
https://ClinicalTrials.gov/show/NCT02820662 |
Completed |
Centre Hospitalier Universitaire Dijon |
2018-05-31 |
| NCT02816710 |
Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02816710 |
Completed |
Ruijin Hospital |
2017-09-30 |
| NCT02816073 |
Pattern Scanning Laser Pan-retinal Photocoagulation in Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02816073 |
Completed |
United Christian Hospital |
2013-11-30 |
| NCT02806830 |
Ocular Discomfort Assessment After Intravitreal Injections |
https://ClinicalTrials.gov/show/NCT02806830 |
Completed |
Centre Hospitalier Intercommunal Creteil |
2017-01-31 |
| NCT02780544 |
Infant-parent Skin-to-skin Contact During Screening for Retinopathy |
https://ClinicalTrials.gov/show/NCT02780544 |
Completed |
St. Olavs Hospital |
2016-06-30 |
| NCT02760472 |
A Fatty Acids Study in Preventing Retinopathy of Prematurity |
https://ClinicalTrials.gov/show/NCT02760472 |
Completed |
Queen Silvia Children’s Hospital, Gothenburg, Sweden |
2015-09-30 |
| NCT02753400 |
Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02753400 |
Completed |
Kubota Vision Inc. |
2017-11-30 |
| NCT02718326 |
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR) |
https://ClinicalTrials.gov/show/NCT02718326 |
Completed |
Regeneron Pharmaceuticals |
2018-08-06 |
| NCT04424290 |
HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia |
https://ClinicalTrials.gov/show/NCT04424290 |
Recruiting |
Boehringer Ingelheim |
2022-05-18 |
| NCT02705274 |
PRP vs Bevacizumab for PDR Treatment |
https://ClinicalTrials.gov/show/NCT02705274 |
Completed |
Marashi Eye Clinic |
2017-04-30 |
| NCT02688309 |
Pro-permeability and Pro-fibrosis Factors in the Aqueous of Patients With Retinal Diseases |
https://ClinicalTrials.gov/show/NCT02688309 |
Recruiting |
Johns Hopkins University |
2021-07-31 |
| NCT02683317 |
Enteral Administration of Docosahexaenoic Acid to Prevent Retinopathy of Prematurity |
https://ClinicalTrials.gov/show/NCT02683317 |
Completed |
Coordinación de Investigación en Salud, Mexico |
2017-10-31 |
| NCT02681809 |
A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR |
https://ClinicalTrials.gov/show/NCT02681809 |
Completed |
Oxurion |
2019-11-18 |
| NCT02671864 |
Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy |
https://ClinicalTrials.gov/show/NCT02671864 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2022-04-11 |
| NCT02646670 |
Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02646670 |
Completed |
Instituto de Olhos de Goiania |
2015-10-31 |
| NCT02645383 |
PASCAL Laser Platform Produces Less Pain Responses Compared To Conventional Laser System |
https://ClinicalTrials.gov/show/NCT02645383 |
Completed |
Kocatepe University |
2014-07-31 |
| NCT02640664 |
Rainbow Extension Study |
https://ClinicalTrials.gov/show/NCT02640664 |
Active, not recruiting |
Novartis |
2022-10-30 |
| NCT02634333 |
Anti-VEGF Treatment for Prevention of PDR/DME |
https://ClinicalTrials.gov/show/NCT02634333 |
Active, not recruiting |
Jaeb Center for Health Research |
2020-05-31 |
| NCT02621580 |
Investigating the Structural and Functional Changes to the Retina Following PRP in Diabetic Retinopathy Patients |
https://ClinicalTrials.gov/show/NCT02621580 |
Completed |
Lawson Health Research Institute |
2017-08-31 |
| NCT02620644 |
Retinal Ganglion Cell Complex Changes by Optical Coherence Tomography in Diabetic Patients Without Retinopathy |
https://ClinicalTrials.gov/show/NCT02620644 |
Completed |
Cairo University |
2014-12-31 |
| NCT02590094 |
Comparison of Interval Variation and Dosage in Preoperative Bevacizumab and Ziv-Aflibercept Administration in Proliferative Diabetic Retinopathy Undergoing Vitrectomy |
https://ClinicalTrials.gov/show/NCT02590094 |
Recruiting |
Panhandle Eye Group, LLP |
2021-10-31 |
| NCT02587741 |
Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens |
https://ClinicalTrials.gov/show/NCT02587741 |
Recruiting |
Third Affiliated Hospital, Sun Yat-Sen University |
2023-07-31 |
| NCT02582164 |
Long-Working Distance OCT for Children |
https://ClinicalTrials.gov/show/NCT02582164 |
Completed |
Duke University |
2018-07-01 |
| NCT04120077 |
Combined Effects of Diabetes Self-Management Education and Nutritional Supplementation on Visual Function and Retinopathy |
https://ClinicalTrials.gov/show/NCT04120077 |
Recruiting |
ZeaVision, LLC |
2020-11-01 |
| NCT04117022 |
Diabetic Retinopathy Functional Evaluation Study: Monitoring Carotenoid Vitamins Treatment Using ERG |
https://ClinicalTrials.gov/show/NCT04117022 |
Recruiting |
ZeaVision, LLC |
2020-12-01 |
| NCT03011541 |
Stem Cell Ophthalmology Treatment Study II |
https://ClinicalTrials.gov/show/NCT03011541 |
Recruiting |
MD Stem Cells |
2022-01-31 |
| NCT02559180 |
Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab |
https://ClinicalTrials.gov/show/NCT02559180 |
Recruiting |
The Cleveland Clinic |
2020-11-30 |
| NCT02543229 |
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentisâ„¢ in Patients With Wet AMD |
https://ClinicalTrials.gov/show/NCT02543229 |
Completed |
Opthea Limited |
2017-02-07 |
| NCT02510885 |
SD-OCT Angiography |
https://ClinicalTrials.gov/show/NCT02510885 |
Recruiting |
Duke University |
2020-05-31 |
| NCT02486484 |
Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection |
https://ClinicalTrials.gov/show/NCT02486484 |
Recruiting |
Rafic Hariri University Hospital |
2019-05-31 |
| NCT02486042 |
Omega-3 LCPUFA Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of Prematurity |
https://ClinicalTrials.gov/show/NCT02486042 |
Recruiting |
University of California, San Diego |
2019-12-31 |
| NCT02475109 |
Study of Topical Ocular PAN-90806 in PDR |
https://ClinicalTrials.gov/show/NCT02475109 |
Completed |
PanOptica, Inc. |
2016-05-31 |
| NCT02447185 |
25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical Trial |
https://ClinicalTrials.gov/show/NCT02447185 |
Recruiting |
The First People’s Hospital of Xuzhou |
2020-12-31 |
| NCT02435862 |
A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02435862 |
Completed |
Allegro Ophthalmics, LLC |
2017-08-10 |
| NCT02432547 |
Laser Therapy Combined With Intravitreal Aflibercept vs Intravitreal Aflibercept Monotherapy (LADAMO) |
https://ClinicalTrials.gov/show/NCT02432547 |
Active, not recruiting |
University of Sydney |
2021-01-31 |
| NCT02390531 |
Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity |
https://ClinicalTrials.gov/show/NCT02390531 |
Active, not recruiting |
Jaeb Center for Health Research |
2019-06-04 |
| NCT02375971 |
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity |
https://ClinicalTrials.gov/show/NCT02375971 |
Completed |
Novartis |
2017-12-14 |
| NCT02315170 |
Assessment of Novel Intraocular Injection Guide |
https://ClinicalTrials.gov/show/NCT02315170 |
Completed |
Maturi, Raj K., M.D., P.C. |
2015-01-31 |
| NCT02277119 |
Clinical Study of the Optic Disc Parameters |
https://ClinicalTrials.gov/show/NCT02277119 |
Completed |
Topcon Medical Systems, Inc. |
2015-01-31 |
| NCT02222610 |
Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy. |
https://ClinicalTrials.gov/show/NCT02222610 |
Completed |
Greater Houston Retina Research |
2019-02-28 |
| NCT02207712 |
Noctura400 Treatment for Diabetic Retinopathy (CANDLE) |
https://ClinicalTrials.gov/show/NCT02207712 |
Active, not recruiting |
PolyPhotonix Medical |
2020-07-31 |
| NCT02164604 |
Lucentis to Treat Retinopathy of Prematurity (ROP) 3 Plus Disease |
https://ClinicalTrials.gov/show/NCT02164604 |
Completed |
Kantonsspital Aarau |
2013-10-31 |
| NCT02157350 |
The Individually Marked Panretinal lasEr phoTokoagUlation for Proliferative Diabetic Retinopathy Study - DETECT |
https://ClinicalTrials.gov/show/NCT02157350 |
Completed |
Odense University Hospital |
2017-09-30 |
| NCT02157077 |
Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT02157077 |
Completed |
Centre Hospitalier Intercommunal Creteil |
2015-12-31 |
| NCT02151695 |
Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy. |
https://ClinicalTrials.gov/show/NCT02151695 |
Completed |
Poitiers University Hospital |
2018-10-31 |
| NCT02134457 |
Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity |
https://ClinicalTrials.gov/show/NCT02134457 |
Completed |
University Hospital Freiburg |
2017-01-31 |
| NCT02121340 |
Collaborative Care for Depression and Diabetic Retinopathy in African Americans |
https://ClinicalTrials.gov/show/NCT02121340 |
Completed |
Thomas Jefferson University |
2018-12-31 |
| NCT02102711 |
Oral Vitamin A Supplementation in Neonates With Birth Weight < 1500 g |
https://ClinicalTrials.gov/show/NCT02102711 |
Completed |
IRCCS Policlinico S. Matteo |
2015-04-30 |
| NCT02099981 |
Restoration of Retinal Vascular Responses in Type 1 Diabetic Patients |
https://ClinicalTrials.gov/show/NCT02099981 |
Completed |
University of Minnesota |
2017-12-31 |
| NCT02085681 |
Study of Effectiveness of Telemedicine in Identifying Diabetic Retinopathy Cases |
https://ClinicalTrials.gov/show/NCT02085681 |
Completed |
Aravind Eye Care System |
2015-01-31 |
| NCT02062034 |
Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02062034 |
Completed |
University of Guadalajara |
2013-11-30 |
| NCT01298076 |
Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema |
https://ClinicalTrials.gov/show/NCT01298076 |
Completed |
University of Sydney |
2014-09-30 |
| NCT01295775 |
Diabetic Retinopathy Sulodexide Study |
https://ClinicalTrials.gov/show/NCT01295775 |
Completed |
Ajou University School of Medicine |
2011-04-30 |
| NCT01281098 |
Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR. |
https://ClinicalTrials.gov/show/NCT01281098 |
Completed |
Association for Innovation and Biomedical Research on Light and Image |
2012-10-31 |
| NCT01280929 |
Prospective, Randomized, Multicenter, Open Label, Phase II Study to Access Efficacy and Safety of Lucentis® Monotherapy Compared With Lucentis® Plus Panretinal Photocoagulation (PRP) and PRP in the Treatment of Patients With High Risk Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01280929 |
Completed |
Association for Innovation and Biomedical Research on Light and Image |
2013-12-31 |
| NCT01270542 |
Avastin for PDR (Proliferative Diabetic Retinopathy) |
https://ClinicalTrials.gov/show/NCT01270542 |
Completed |
University of Southern California |
2011-07-31 |
| NCT02040441 |
Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria |
https://ClinicalTrials.gov/show/NCT02040441 |
Completed |
Steno Diabetes Center Copenhagen |
2018-11-30 |
| NCT02036632 |
Eye Patch Therapy for Central Serous Retinopathy (CSR) |
https://ClinicalTrials.gov/show/NCT02036632 |
Completed |
Washington University School of Medicine |
2015-01-31 |
| NCT04005352 |
Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON) |
https://ClinicalTrials.gov/show/NCT04005352 |
Recruiting |
Novartis |
2022-01-31 |
| NCT02014454 |
Safety and Efficacy of Propranolol Eye Drops in Treating Retinopathy of Premature |
https://ClinicalTrials.gov/show/NCT02014454 |
Completed |
Azienda Ospedaliero, Universitaria Meyer |
2014-08-31 |
| NCT01988246 |
Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery |
https://ClinicalTrials.gov/show/NCT01988246 |
Completed |
The Cleveland Clinic |
2018-04-25 |
| NCT01976923 |
Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01976923 |
Completed |
King Khaled Eye Specialist Hospital |
2018-07-31 |
| NCT01955135 |
Anesthesia for Retinopathy of Prematurity |
https://ClinicalTrials.gov/show/NCT01955135 |
Completed |
TC Erciyes University |
2012-12-31 |
| NCT01950663 |
RETeval Study for Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01950663 |
Completed |
Inoveon Corporation |
2014-04-30 |
| NCT01941329 |
Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy. |
https://ClinicalTrials.gov/show/NCT01941329 |
Completed |
Association for Innovation and Biomedical Research on Light and Image |
2016-04-30 |
| NCT01927315 |
Effects of Fenofibrate on Endothelial Progenitor Cells in Diabetes |
https://ClinicalTrials.gov/show/NCT01927315 |
Completed |
University of Padova |
2019-10-31 |
| NCT01920867 |
Stem Cell Ophthalmology Treatment Study |
https://ClinicalTrials.gov/show/NCT01920867 |
Enrolling by invitation |
MD Stem Cells |
2020-07-31 |
| NCT01875783 |
OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits |
https://ClinicalTrials.gov/show/NCT01875783 |
Completed |
Joslin Diabetes Center |
2015-05-14 |
| NCT01875510 |
The Influence of Fish-oil Lipid Emulsions on Neonatal Morbidities |
https://ClinicalTrials.gov/show/NCT01875510 |
Completed |
Dr. Sami Ulus Children’s Hospital |
2013-09-30 |
| NCT01872611 |
Nepafenac Once Daily for Macular Edema - Study 2 |
https://ClinicalTrials.gov/show/NCT01872611 |
Completed |
Alcon Research |
2015-05-31 |
| NCT01869933 |
Phase I Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10X |
https://ClinicalTrials.gov/show/NCT01869933 |
Completed |
OcuCure Therapeutics, Inc. |
2013-06-30 |
| NCT01854593 |
Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01854593 |
Completed |
Nihon University |
2013-08-31 |
| NCT01837121 |
a Trial of Using SMS Reminder Among Diabetic Retinopathy Patients in Rural China |
https://ClinicalTrials.gov/show/NCT01837121 |
Completed |
Sun Yat-sen University |
2017-06-30 |
| NCT01813773 |
Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study |
https://ClinicalTrials.gov/show/NCT01813773 |
Completed |
Ophthalmic Consultants of Long Island |
2016-04-30 |
| NCT01805297 |
Aflibercept Injection for Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01805297 |
Completed |
University of Oklahoma |
2014-02-28 |
| NCT01787669 |
Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema |
https://ClinicalTrials.gov/show/NCT01787669 |
Completed |
University of Sydney |
2017-01-31 |
| NCT01769183 |
Squalamine for the Treatment in Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01769183 |
Completed |
Elman Retina Group |
2014-08-31 |
| NCT01758757 |
Comparison of Small-gauge Vitrectomy and Conventional Vitrectomy for Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01758757 |
Completed |
Kyorin University |
2011-01-31 |
| NCT01753648 |
Non-invasive Measurement of Retinal Blood Flow Based on Vessel Analysis and Fourier Domain Optical Coherence Tomography in Patients With Hypertensive Retinopathy |
https://ClinicalTrials.gov/show/NCT01753648 |
Recruiting |
Medical University of Vienna |
2020-09-30 |
| NCT01746563 |
Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01746563 |
Completed |
University of Sao Paulo |
2012-08-31 |
| NCT01743781 |
Uptake of Comprehensive Eye Examination Trial |
https://ClinicalTrials.gov/show/NCT01743781 |
Completed |
Sun Yat-sen University |
2013-09-30 |
| NCT01736059 |
Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy |
https://ClinicalTrials.gov/show/NCT01736059 |
Enrolling by invitation |
University of California, Davis |
2022-01-31 |
| NCT01726075 |
Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01726075 |
Completed |
BCN Peptides |
2015-11-30 |
| NCT01724554 |
Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion |
https://ClinicalTrials.gov/show/NCT01724554 |
Completed |
Ophthalmic Consultants of Boston |
2014-10-31 |
| NCT01724385 |
Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01724385 |
Completed |
Khon Kaen University |
2012-12-31 |
| NCT01694212 |
Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01694212 |
Completed |
Eye Clinic Medic Zuljan Jukic |
2016-10-31 |
| NCT01660620 |
Topical Betaxolol for the Prevention of Retinopathy of Prematurity |
https://ClinicalTrials.gov/show/NCT01660620 |
Completed |
Smith-Kettlewell Eye Research Institute |
2011-11-30 |
| NCT01646047 |
Diabetes Visual Function Supplement Study |
https://ClinicalTrials.gov/show/NCT01646047 |
Completed |
ZeaVision, LLC |
2014-08-31 |
| NCT01628289 |
The Cost-effectiveness of Screening for Diabetic Retinopathy in Hong Kong |
https://ClinicalTrials.gov/show/NCT01628289 |
Completed |
The University of Hong Kong |
2009-08-31 |
| NCT01594281 |
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE) |
https://ClinicalTrials.gov/show/NCT01594281 |
Completed |
Novartis |
2016-11-30 |
| NCT01579760 |
Intravitreal Aflibercept Injection for Radiation Retinopathy |
https://ClinicalTrials.gov/show/NCT01579760 |
Completed |
Washington University School of Medicine |
2019-01-31 |
| NCT01571232 |
Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01571232 |
Completed |
Retina Macula Institute |
2014-02-28 |
| NCT01535495 |
Propranolol for Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01535495 |
Completed |
University of Wisconsin, Madison |
2015-12-31 |
| NCT01518842 |
Effect of Intravitreal Bone Marrow Stem Cells on Ischemic Retinopathy |
https://ClinicalTrials.gov/show/NCT01518842 |
Active, not recruiting |
University of Sao Paulo |
2018-10-31 |
| NCT01489189 |
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01489189 |
Completed |
Jaeb Center for Health Research |
2015-01-31 |
| NCT01482195 |
Trial of Ocular Subretinal Injection of a Recombinant Adeno-Associated Virus (rAAV2-VMD2-hMERTK) Gene Vector to Patients With Retinal Disease Due to MERTK Mutations |
https://ClinicalTrials.gov/show/NCT01482195 |
Recruiting |
King Khaled Eye Specialist Hospital |
2014-08-31 |
| NCT01468337 |
Topical Interferon Gamma-1b for Central Serous Chorioretinopathy |
https://ClinicalTrials.gov/show/NCT01468337 |
Completed |
National Institutes of Health Clinical Center (CC) |
2013-11-30 |
| NCT01404247 |
Spectral Domain Optical Coherence Tomography Imaging of the Eyes of Neonates |
https://ClinicalTrials.gov/show/NCT01404247 |
Completed |
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center |
2015-12-31 |
| NCT01399515 |
Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT01399515 |
Completed |
Seoul National University Hospital |
2013-08-31 |
| NCT01383772 |
Retinal Laser by Multi-spot Photocoagulator and Driving Eligibility |
https://ClinicalTrials.gov/show/NCT01383772 |
Completed |
Moorfields Eye Hospital NHS Foundation Trust |
2014-08-31 |
| NCT01373476 |
Multicentre, Randomized, Controlled Trial of Qideng Mingmu Capsule in The Treatment of Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01373476 |
Completed |
Chengdu University of Traditional Chinese Medicine |
2013-03-31 |
| NCT01364129 |
The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01364129 |
Completed |
Legacy Health System |
2011-12-31 |
| NCT01334879 |
High Dose Intravitreal Ranibizumab for Recalcitrant Radiation Retinopathy |
https://ClinicalTrials.gov/show/NCT01334879 |
Completed |
The New York Eye Cancer Center |
2012-11-30 |
| NCT01323348 |
Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control |
https://ClinicalTrials.gov/show/NCT01323348 |
Completed |
Jaeb Center for Health Research |
2014-07-31 |
| NCT01320345 |
The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. |
https://ClinicalTrials.gov/show/NCT01320345 |
Recruiting |
University of Sydney |
2022-01-31 |
| NCT02617966 |
Rod and Cone Mediated Function in Retinal Disease |
https://ClinicalTrials.gov/show/NCT02617966 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2024-12-30 |
| NCT04418427 |
ADVM-022 Intravitreal Gene Therapy for DME |
https://ClinicalTrials.gov/show/NCT04418427 |
Recruiting |
Adverum Biotechnologies, Inc. |
2021-05-31 |
| NCT04408807 |
Stress Induced by Screening for Retinopathy of Prematurity - Should Speculum and Indentation Rather be Avoided |
https://ClinicalTrials.gov/show/NCT04408807 |
Completed |
Aristotle University Of Thessaloniki |
2020-02-04 |
| NCT04380077 |
Gas Tamponade for Prevention of Postoperative Vitreous Hemorrhage in Diabetics |
https://ClinicalTrials.gov/show/NCT04380077 |
Recruiting |
Rush Eye Associates |
2024-06-01 |
| NCT04380064 |
Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT04380064 |
Recruiting |
Rush Eye Associates |
2024-06-01 |
| NCT04285151 |
Nd:YAG Laser Hyaloidotomy for Premacular Hemorrhage in Diabetic Eyes |
https://ClinicalTrials.gov/show/NCT04285151 |
Completed |
Tanta University |
2020-01-31 |
| NCT04265261 |
A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT04265261 |
Recruiting |
Hoffmann-La Roche |
2022-02-09 |
| NCT04255732 |
Comparison of Wide-field Retinal Imaging |
https://ClinicalTrials.gov/show/NCT04255732 |
Recruiting |
Vienna Institute for Research in Ocular Surgery |
2020-10-31 |
| NCT04246866 |
First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT04246866 |
Recruiting |
Gemini Therapeutics, Inc. |
2020-05-31 |
| NCT04222387 |
Investigation of Potential Retinal Toxicity Associated With Hair Dye Products Containing pPD Type Aromatic Amines |
https://ClinicalTrials.gov/show/NCT04222387 |
Recruiting |
Fondation Ophtalmologique Adolphe de Rothschild |
2020-12-31 |
| NCT04191954 |
Fasudil Eye Drop in Retinopathy Of Prematurity(ROP) |
https://ClinicalTrials.gov/show/NCT04191954 |
Recruiting |
Shahid Beheshti University of Medical Sciences |
2019-11-01 |
| NCT04187443 |
MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema |
https://ClinicalTrials.gov/show/NCT04187443 |
Recruiting |
MingSight Pharmaceuticals Pty Limited |
2021-08-18 |
| NCT04130841 |
Effects of Internal Limiting Membrane Peeling on Visual Function in Epiretinal Membrane Surgery |
https://ClinicalTrials.gov/show/NCT04130841 |
Recruiting |
Seoul National University Hospital |
2020-09-29 |
| NCT04123626 |
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene |
https://ClinicalTrials.gov/show/NCT04123626 |
Recruiting |
ProQR Therapeutics |
2021-10-07 |
| NCT04120636 |
Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole |
https://ClinicalTrials.gov/show/NCT04120636 |
Recruiting |
Targeted Therapy Technologies, LLC |
2020-10-30 |
| NCT04120311 |
Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole |
https://ClinicalTrials.gov/show/NCT04120311 |
Recruiting |
Targeted Therapy Technologies, LLC |
2020-08-25 |
| NCT04103671 |
Pars-plana Vitrectomy vs Panretinal Photocoagulation for Severe NPDR |
https://ClinicalTrials.gov/show/NCT04103671 |
Recruiting |
Zhongshan Ophthalmic Center, Sun Yat-sen University |
2021-12-31 |
| NCT04068831 |
Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT04068831 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2022-08-31 |
| NCT04038125 |
Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME |
https://ClinicalTrials.gov/show/NCT04038125 |
Recruiting |
Retina Macula Specialists of Miami, LLC |
2020-08-31 |
| NCT04015180 |
Extension Study to Evaluate the Long-term Outcomes of Subjects in Study 20090 |
https://ClinicalTrials.gov/show/NCT04015180 |
Recruiting |
Bayer |
2025-05-15 |
| NCT04009980 |
Long-term Retinal Changes After Topical Citicoline Administration in Patients With Mild Signs of Diabetic Retinopathy in Type 1 Diabetes Mellitus. |
https://ClinicalTrials.gov/show/NCT04009980 |
Completed |
Fondazione G.B. Bietti, IRCCS |
2018-10-31 |
| NCT04008771 |
Intravitreal Injection of SeeQ CdSe 655 Alt Nanoparticles for Patients With Degenerative Retinal Diseases |
https://ClinicalTrials.gov/show/NCT04008771 |
Completed |
2C Tech Corp |
2014-12-19 |
| NCT04004208 |
Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy |
https://ClinicalTrials.gov/show/NCT04004208 |
Recruiting |
Bayer |
2021-01-15 |
| NCT03970161 |
Evaluation of Early Retinal Nerve Injury in Type 2 Diabetes Patients Without Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT03970161 |
Recruiting |
Third Affiliated Hospital, Sun Yat-Sen University |
2021-06-01 |
| NCT03962296 |
A Multicenter, Randomized, Double-blind Non-inferiority Trial to Evaluate the Efficacy and Safety of Entelon® |
https://ClinicalTrials.gov/show/NCT03962296 |
Completed |
Hanyang University |
2015-01-26 |
| NCT03954626 |
Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD |
https://ClinicalTrials.gov/show/NCT03954626 |
Completed |
Novartis |
2019-07-09 |
| NCT03913143 |
A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE) |
https://ClinicalTrials.gov/show/NCT03913143 |
Recruiting |
ProQR Therapeutics |
2020-12-31 |
| NCT03913130 |
Extension Study to Study PQ-110-001 (NCT03140969) |
https://ClinicalTrials.gov/show/NCT03913130 |
Active, not recruiting |
ProQR Therapeutics |
2021-03-31 |
| NCT03904056 |
ETDRS PRP With IVR Versus Retinal Photocoagulation Targeted to Ischemic Retina With IVR for the Treatment of PDR |
https://ClinicalTrials.gov/show/NCT03904056 |
Completed |
São Paulo State University |
2017-07-01 |
| NCT03902925 |
Pain During Pars Plana Vitrectomy With Sub-tenon Anesthesia |
https://ClinicalTrials.gov/show/NCT03902925 |
Completed |
University of Sao Paulo |
2019-08-31 |
| NCT03901898 |
Feasibility of an Intervention to Increase Diabetic Retinopathy Screening Attendance |
https://ClinicalTrials.gov/show/NCT03901898 |
Active, not recruiting |
University College Cork |
2020-06-30 |
| NCT00837252 |
Pilot Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy |
https://ClinicalTrials.gov/show/NCT00837252 |
Completed |
National Institutes of Health Clinical Center (CC) |
2010-04-30 |
| NCT03872479 |
Single Ascending Dose Study in Participants With LCA10 |
https://ClinicalTrials.gov/show/NCT03872479 |
Recruiting |
Allergan |
2024-03-22 |
| NCT03868462 |
Optos P200TE Agreement and Precision Study |
https://ClinicalTrials.gov/show/NCT03868462 |
Completed |
Optos, PLC |
2019-09-16 |
| NCT03863535 |
PRP vs PRP+IVC for Severe nPDR |
https://ClinicalTrials.gov/show/NCT03863535 |
Recruiting |
Ruijin Hospital |
2021-01-01 |
| NCT03780257 |
Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene |
https://ClinicalTrials.gov/show/NCT03780257 |
Recruiting |
ProQR Therapeutics |
2021-12-31 |
| NCT03765112 |
Macular Involvement in Diabetic Retinopathy Evaluated With Swept-Source OCT |
https://ClinicalTrials.gov/show/NCT03765112 |
Recruiting |
University of British Columbia |
2019-12-31 |
| NCT03712670 |
Nutraceutical Support With Omega-3 |
https://ClinicalTrials.gov/show/NCT03712670 |
Completed |
Università degli Studi di Brescia |
2016-12-31 |
| NCT03702374 |
Combined Antioxidant Therapy on Oxidative Stress, Mitochondrial Dysfunction Markers in Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT03702374 |
Recruiting |
University of Guadalajara |
2021-01-31 |
| NCT03680794 |
Soluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic Retinopathies |
https://ClinicalTrials.gov/show/NCT03680794 |
Recruiting |
CHU de Reims |
2021-12-01 |
| NCT03672656 |
Pattern Laser Versus Conventional Laser in Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT03672656 |
Completed |
University Hospital Ostrava |
2013-12-31 |
| NCT03660384 |
Silicone Oil Versus Long-acting Gas Tamponade in Proliferative Diabetic Retinopathy Patients With High-grade Vitreoretinal Adhesion Undergoing Vitrectomy |
https://ClinicalTrials.gov/show/NCT03660384 |
Recruiting |
Rush Eye Associates |
2020-09-04 |
| NCT03660371 |
Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy for Vitreous Hemorrhaging |
https://ClinicalTrials.gov/show/NCT03660371 |
Recruiting |
Rush Eye Associates |
2020-09-04 |
| NCT03650621 |
Magnetic Non-Invasive Acupuncture For Infant Comfort A Pilot Study in Preterm Infants Requiring Eye-exam for Retinopathy of Prematurity |
https://ClinicalTrials.gov/show/NCT03650621 |
Active, not recruiting |
University of Alberta |
2019-09-30 |
| NCT03531294 |
Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement |
https://ClinicalTrials.gov/show/NCT03531294 |
Active, not recruiting |
Greater Houston Retina Research |
2021-04-30 |
| NCT03505567 |
Study to Compare Kowa OCT Bi-μ and the Optovue iVue 100 |
https://ClinicalTrials.gov/show/NCT03505567 |
Completed |
Kowa Research Institute, Inc. |
2018-09-01 |
| NCT03478306 |
Diabetic Retinopathy: Effects of Melatonin Treatment on Visual Functions and Circadian Rhythm |
https://ClinicalTrials.gov/show/NCT03478306 |
Recruiting |
Glostrup University Hospital, Copenhagen |
2020-10-01 |
| NCT03475173 |
New Non-invasive Modalities for Assessing Retinal Structure and Function |
https://ClinicalTrials.gov/show/NCT03475173 |
Recruiting |
University of Iowa |
2020-01-01 |
| NCT03439345 |
Lowering Events in Non-proliferative Retinopathy in Scotland |
https://ClinicalTrials.gov/show/NCT03439345 |
Recruiting |
University of Oxford |
2023-08-31 |
| NCT03426540 |
Intravitreal Conbercept After Vitrectomy |
https://ClinicalTrials.gov/show/NCT03426540 |
Completed |
Tianjin Medical University Eye Hospital |
2018-03-30 |
| NCT03422965 |
Perifoveal Vascular Network Assessed by OCT-Angiography in Type I Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT03422965 |
Recruiting |
Hospital Clinic of Barcelona |
2019-05-08 |
| NCT01257815 |
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment |
https://ClinicalTrials.gov/show/NCT01257815 |
Completed |
Novartis |
2013-04-30 |
| NCT01255293 |
Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments |
https://ClinicalTrials.gov/show/NCT01255293 |
Completed |
Mid Atlantic Retina |
2012-10-31 |
| NCT01238471 |
Oral Propranolol Versus Placebo for Early Stages of Retinopathy of Prematurity: A Randomized and Prospective Study |
https://ClinicalTrials.gov/show/NCT01238471 |
Completed |
Rambam Health Care Campus |
2012-05-31 |
| NCT01227993 |
Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy |
https://ClinicalTrials.gov/show/NCT01227993 |
Completed |
National Institutes of Health Clinical Center (CC) |
2012-12-31 |
| NCT01225653 |
Topical Application of Latanoprost in Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01225653 |
Completed |
University of Aarhus |
2014-12-31 |
| NCT01205035 |
High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia |
https://ClinicalTrials.gov/show/NCT01205035 |
Completed |
Eye Center of Northern Colorado, P.C. |
2012-10-31 |
| NCT01203436 |
Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity |
https://ClinicalTrials.gov/show/NCT01203436 |
Completed |
NICHD Neonatal Research Network |
1999-03-31 |
| NCT01201161 |
Ranibizumab for Diabetic Traction Retinal Detachment |
https://ClinicalTrials.gov/show/NCT01201161 |
Completed |
University of Sao Paulo |
2010-01-31 |
| NCT01115257 |
Severe Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01115257 |
Completed |
Universita degli Studi di Catania |
2006-10-31 |
| NCT01102946 |
Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01102946 |
Completed |
University of Sao Paulo |
2011-02-28 |
| NCT01100307 |
A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01100307 |
Completed |
Pfizer |
2012-08-31 |
| NCT01096784 |
IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity |
https://ClinicalTrials.gov/show/NCT01096784 |
Completed |
Shire |
2016-03-01 |
| NCT01086631 |
Rituximab for Autoimmune Retinopathy |
https://ClinicalTrials.gov/show/NCT01086631 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01079715 |
Safety and Efficacy of Propranolol in Newborns With Retinopathy of Prematurity |
https://ClinicalTrials.gov/show/NCT01079715 |
Completed |
Azienda Ospedaliero, Universitaria Meyer |
2012-10-31 |
| NCT01069341 |
Use of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract Surgery |
https://ClinicalTrials.gov/show/NCT01069341 |
Completed |
Bhagat, Neelakshi, M.D., M.P.H. |
2011-12-31 |
| NCT01054027 |
Study on Effective Mydriasis in Premature Infants |
https://ClinicalTrials.gov/show/NCT01054027 |
Completed |
Georgetown University |
2007-11-30 |
| NCT01041690 |
Efficacy of PreOperative Bevacizumab for Diabetic Eye Disease |
https://ClinicalTrials.gov/show/NCT01041690 |
Completed |
Cairo University |
2008-06-30 |
| NCT01025934 |
Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01025934 |
Completed |
University of Campania “Luigi Vanvitelli” |
NA |
| NCT01024803 |
Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients |
https://ClinicalTrials.gov/show/NCT01024803 |
Completed |
Retina Implant AG |
2017-04-30 |
| NCT01016873 |
INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD |
https://ClinicalTrials.gov/show/NCT01016873 |
Completed |
Oraya Therapeutics, Inc. |
2012-05-31 |
| NCT00996437 |
Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) |
https://ClinicalTrials.gov/show/NCT00996437 |
Completed |
Jaeb Center for Health Research |
2012-02-29 |
| NCT00970723 |
High Blood Pressure and Sleep Apnea in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00970723 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2014-01-31 |
| NCT00921544 |
Sucrose Analgesia for the Reduction of Pain During Retinopathy of Prematurity Screening |
https://ClinicalTrials.gov/show/NCT00921544 |
Completed |
Coombe Women and Infants University Hospital |
2009-03-31 |
| NCT00917553 |
Evaluation of Effect of Doxycycline Verses Placebo on Retinal Function and Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00917553 |
Completed |
Milton S. Hershey Medical Center |
2012-07-31 |
| NCT00907114 |
Topic Ketorolac Added to Panphotocoagulation in Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00907114 |
Completed |
Hospital Juarez de Mexico |
2015-03-31 |
| NCT00904592 |
A Study on Traditional Chinese Medicine (TCM) Comprehensive Protocol of Prevention and Control in Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00904592 |
Completed |
Chengdu University of Traditional Chinese Medicine |
2010-10-31 |
| NCT00900887 |
Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema |
https://ClinicalTrials.gov/show/NCT00900887 |
Completed |
Hospital Juarez de Mexico |
2015-03-31 |
| NCT00821340 |
Clinical Trial of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations |
https://ClinicalTrials.gov/show/NCT00821340 |
Completed |
Hadassah Medical Organization |
2016-06-29 |
| NCT04071977 |
Combined Antioxidant Therapy on Oxidative Stress in Aqueous and Vitreous Humor of Diabetic Retinopathy Patients |
https://ClinicalTrials.gov/show/NCT04071977 |
Recruiting |
University of Guadalajara |
2021-01-31 |
| NCT02504944 |
Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%) |
https://ClinicalTrials.gov/show/NCT02504944 |
Completed |
Azienda Ospedaliero, Universitaria Meyer |
2018-08-31 |
| NCT00812760 |
Effect of Levodopa on Human Multifocal Electroretinogram |
https://ClinicalTrials.gov/show/NCT00812760 |
Completed |
Medical University of Vienna |
2003-10-31 |
| NCT01853072 |
Nepafenac Once Daily for Macular Edema - Study 1 |
https://ClinicalTrials.gov/show/NCT01853072 |
Completed |
Alcon Research |
2015-05-31 |
| NCT00806169 |
Combined Triple Therapy in Diabetic Retinopathy (DRP) |
https://ClinicalTrials.gov/show/NCT00806169 |
Completed |
Johann Wolfgang Goethe University Hospital |
2008-10-31 |
| NCT03846193 |
First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD |
https://ClinicalTrials.gov/show/NCT03846193 |
Recruiting |
Gyroscope Therapeutics |
2021-06-30 |
| NCT00804921 |
Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab |
https://ClinicalTrials.gov/show/NCT00804921 |
Completed |
University of Sao Paulo |
NA |
| NCT00804102 |
Transcorneal Electrical Stimulation Therapy for Retinal Disease |
https://ClinicalTrials.gov/show/NCT00804102 |
Completed |
Okuvision GmbH |
2011-04-30 |
| NCT00802269 |
Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy. |
https://ClinicalTrials.gov/show/NCT00802269 |
Completed |
Asociación para Evitar la Ceguera en México |
2008-11-30 |
| NCT02521116 |
Comparison of Retinal Oxygenation and Retinal Vessel Diameters in Healthy Subjects and Patients With Diabetic Retinopathy or Retinal Vein Occlusion Between DVA and Oxymap |
https://ClinicalTrials.gov/show/NCT02521116 |
Completed |
Medical University of Vienna |
2017-01-03 |
| NCT01920984 |
Vitreous Levels of Cysteine-rich 61 in Patients With Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01920984 |
Completed |
National Taiwan University Hospital |
2006-12-31 |
| NCT00782717 |
A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients |
https://ClinicalTrials.gov/show/NCT00782717 |
Completed |
Alcon Research |
2010-07-31 |
| NCT00776763 |
Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab |
https://ClinicalTrials.gov/show/NCT00776763 |
Completed |
Ophthalmological Association Edelweiss |
2009-10-31 |
| NCT00750399 |
Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma |
https://ClinicalTrials.gov/show/NCT00750399 |
Completed |
The New York Eye Cancer Center |
2011-09-30 |
| NCT00745498 |
Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic Vitrectomy |
https://ClinicalTrials.gov/show/NCT00745498 |
Completed |
Seoul National University Bundang Hospital |
2010-10-31 |
| NCT00711490 |
Sirolimus to Treat Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00711490 |
Completed |
National Institutes of Health Clinical Center (CC) |
2011-01-31 |
| NCT00690768 |
Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV to Treat Diabetic Tractional Retinal Detachment (IBETRA) |
https://ClinicalTrials.gov/show/NCT00690768 |
Completed |
University of Sao Paulo |
2008-05-31 |
| NCT00682240 |
Morphological and Functional Retinal Changes Following Retinal Photocoagulation |
https://ClinicalTrials.gov/show/NCT00682240 |
Completed |
Medical University of Vienna |
2014-02-28 |
| NCT00665106 |
Safety and Tolerability of NOVA63035 “Corticosteroid” in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00665106 |
Completed |
Santen SAS |
2011-09-30 |
| NCT00656435 |
Bevacizumab and Long Acting Gas in Diabetic Vitrectomy |
https://ClinicalTrials.gov/show/NCT00656435 |
Completed |
National Taiwan University Hospital |
2007-08-31 |
| NCT00648687 |
Pain Response During Examination for Retinopathy of Prematurity |
https://ClinicalTrials.gov/show/NCT00648687 |
Completed |
National Bioethics Commission of Brazil |
2010-06-30 |
| NCT00623220 |
Inhaled Nitrous Oxide for Pain Relief During Eye Exam in the Pre-term Infant |
https://ClinicalTrials.gov/show/NCT00623220 |
Completed |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2010-04-30 |
| NCT00622726 |
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity |
https://ClinicalTrials.gov/show/NCT00622726 |
Active, not recruiting |
The University of Texas Health Science Center, Houston |
2010-08-31 |
| NCT00619034 |
Pharmacological Intervention in Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00619034 |
Completed |
University of Aarhus |
2010-12-31 |
| NCT00604383 |
Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study |
https://ClinicalTrials.gov/show/NCT00604383 |
Completed |
Chromaderm, Inc. |
2005-06-30 |
| NCT00600262 |
Intravitreal Bevacizumab for Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00600262 |
Completed |
Asociación para Evitar la Ceguera en México |
NA |
| NCT00600236 |
HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population |
https://ClinicalTrials.gov/show/NCT00600236 |
Completed |
Asociación para Evitar la Ceguera en México |
2008-01-31 |
| NCT00596297 |
Preoperative Bevacizumab for Vitreous Hemorrhage |
https://ClinicalTrials.gov/show/NCT00596297 |
Completed |
University of Sao Paulo |
2008-09-30 |
| NCT00563121 |
VEGF Levels in Aqueous, Vitreous and Subretinal Fluid in ROP Stage IV and V |
https://ClinicalTrials.gov/show/NCT00563121 |
Completed |
Asociación para Evitar la Ceguera en México |
NA |
| NCT00548197 |
Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment |
https://ClinicalTrials.gov/show/NCT00548197 |
Completed |
Iran University of Medical Sciences |
2008-02-29 |
| NCT00545870 |
Bevacizumab Versus Ranibizumab for Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00545870 |
Completed |
Medical University of Vienna |
2013-03-31 |
| NCT00542178 |
Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study) |
https://ClinicalTrials.gov/show/NCT00542178 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
2009-12-31 |
| NCT00511875 |
Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00511875 |
Completed |
Milton S. Hershey Medical Center |
2012-05-31 |
| NCT00500396 |
Vascular Endothelial Growth Factor in Stage V ROP |
https://ClinicalTrials.gov/show/NCT00500396 |
Completed |
Asociación para Evitar la Ceguera en México |
NA |
| NCT00500097 |
Diabetic Retinopathy and Diabetic Macular Edema Screening by Non-Physicians With Limited Training |
https://ClinicalTrials.gov/show/NCT00500097 |
Completed |
Ministry of Health, Thailand |
NA |
| NCT00481546 |
Phase I Trial of Gene Vector to Patients With Retinal Disease Due to RPE65 Mutations |
https://ClinicalTrials.gov/show/NCT00481546 |
Active, not recruiting |
University of Pennsylvania |
2026-06-30 |
| NCT00446381 |
Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema) |
https://ClinicalTrials.gov/show/NCT00446381 |
Completed |
Lawson Health Research Institute |
2008-09-30 |
| NCT00445003 |
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00445003 |
Completed |
Jaeb Center for Health Research |
2009-10-31 |
| NCT00444600 |
Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00444600 |
Completed |
Jaeb Center for Health Research |
2009-12-31 |
| NCT00443521 |
Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00443521 |
Completed |
University of Sao Paulo |
NA |
| NCT00437593 |
UHR-OCT and HD-OCT for Preretinal Membranes: ICG Versus Membrane Blue |
https://ClinicalTrials.gov/show/NCT00437593 |
Completed |
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery |
2008-05-31 |
| NCT00799695 |
Diabetic Retina Exam Rate Does Not Increase With Phone Reminders in Non-HMO Population |
https://ClinicalTrials.gov/show/NCT00799695 |
Completed |
Henry Ford Health System |
2008-05-31 |
| NCT00423059 |
Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00423059 |
Completed |
Yonsei University |
NA |
| NCT00422721 |
Genetic Study of Patients Suffering From Congenital Amaurosis of Leber or From an Early Severe Retinal Dystrophy |
https://ClinicalTrials.gov/show/NCT00422721 |
Completed |
Nantes University Hospital |
NA |
| NCT00411333 |
Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00411333 |
Completed |
National Eye Institute (NEI) |
2009-07-31 |
| NCT00406991 |
Retinal Blood Flow and Microthrombi in Type 1 Diabetes |
https://ClinicalTrials.gov/show/NCT00406991 |
Completed |
Massachusetts Eye and Ear Infirmary |
NA |
| NCT00401115 |
Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00401115 |
Completed |
Santen Inc. |
2008-06-30 |
| NCT00387582 |
Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00387582 |
Completed |
Rocky Mountain Retina Consultants |
2009-02-28 |
| NCT00385333 |
Metabolic Mapping to Measure Retinal Metabolism |
https://ClinicalTrials.gov/show/NCT00385333 |
Completed |
National Institutes of Health Clinical Center (CC) |
2008-06-01 |
| NCT00370851 |
Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial |
https://ClinicalTrials.gov/show/NCT00370851 |
Completed |
Shahid Beheshti University of Medical Sciences |
2008-02-29 |
| NCT00355680 |
Green Laser Photocoagulation Study in Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00355680 |
Completed |
Aurolab |
2006-07-31 |
| NCT00337298 |
The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 Diabetes |
https://ClinicalTrials.gov/show/NCT00337298 |
Completed |
University of Aarhus |
2009-02-28 |
| NCT00252733 |
Diabetic Retinopathy Candesartan Trials |
https://ClinicalTrials.gov/show/NCT00252733 |
Completed |
AstraZeneca |
2008-04-30 |
| NCT00252720 |
DIabetic Retinopathy Candesartan Trials. |
https://ClinicalTrials.gov/show/NCT00252720 |
Completed |
AstraZeneca |
2008-02-29 |
| NCT00252694 |
DIabetic Retinopathy Candesartan Trials |
https://ClinicalTrials.gov/show/NCT00252694 |
Completed |
AstraZeneca |
2008-02-29 |
| NCT00231023 |
Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00231023 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00198471 |
Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment |
https://ClinicalTrials.gov/show/NCT00198471 |
Completed |
Bausch & Lomb Incorporated |
2006-11-30 |
| NCT00174824 |
Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic Patients |
https://ClinicalTrials.gov/show/NCT00174824 |
Completed |
Sanofi |
2007-04-30 |
| NCT00155454 |
Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy |
https://ClinicalTrials.gov/show/NCT00155454 |
Completed |
National Taiwan University Hospital |
2012-12-31 |
| NCT00131144 |
Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00131144 |
Completed |
Novartis |
2005-12-31 |
| NCT00130845 |
Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00130845 |
Completed |
Novartis |
2005-12-31 |
| NCT00119535 |
Study to Evaluate the Effectiveness of a Program Developed to Improve Eye Care for Veterans With Diabetes |
https://ClinicalTrials.gov/show/NCT00119535 |
Completed |
VA Office of Research and Development |
NA |
| NCT00101764 |
Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders |
https://ClinicalTrials.gov/show/NCT00101764 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00035906 |
Research Study in Patients With Persistent Macular Edema |
https://ClinicalTrials.gov/show/NCT00035906 |
Completed |
Allergan |
2004-08-31 |
| NCT00295828 |
A Pilot Study for the Treatment of Iris Neovascularization With Macugen |
https://ClinicalTrials.gov/show/NCT00295828 |
Completed |
Hermann Eye Center |
2008-09-30 |
| NCT00001865 |
HAT in Eye Complications of Behcet’s Disease |
https://ClinicalTrials.gov/show/NCT00001865 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00000160 |
Diabetic Retinopathy Study (DRS) |
https://ClinicalTrials.gov/show/NCT00000160 |
Completed |
National Eye Institute (NEI) |
NA |
| NCT00000159 |
Sorbinil Retinopathy Trial (SRT) |
https://ClinicalTrials.gov/show/NCT00000159 |
Completed |
National Eye Institute (NEI) |
NA |
| NCT00000156 |
The Effects of Light Reduction on Retinopathy of Prematurity (Light-ROP) |
https://ClinicalTrials.gov/show/NCT00000156 |
Completed |
National Eye Institute (NEI) |
NA |
| NCT00000154 |
Diabetic Retinopathy Vitrectomy Study (DRVS) |
https://ClinicalTrials.gov/show/NCT00000154 |
Completed |
National Eye Institute (NEI) |
NA |
| NCT00000151 |
Early Treatment Diabetic Retinopathy Study (ETDRS) |
https://ClinicalTrials.gov/show/NCT00000151 |
Completed |
National Eye Institute (NEI) |
NA |
| NCT00000133 |
Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) - Outcome Study of Cryotherapy for Retinopathy of Prematurity |
https://ClinicalTrials.gov/show/NCT00000133 |
Completed |
National Eye Institute (NEI) |
NA |
| NCT00000131 |
Central Vein Occlusion Study (CVOS) |
https://ClinicalTrials.gov/show/NCT00000131 |
Completed |
National Eye Institute (NEI) |
NA |